Evidence map›Paper›PMID 23094644›Full record

ArticleBiochemistry2012

Dss1 release activates DNA binding potential in Brh2.

Qingwen Zhou, Milorad Kojic, William K Holloman

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Qingwen ZhouDepartment of Microbiology and Immunology and Weill Cornell Cancer Center, Weill Cornell Medical College, New York, New York 10065, United States.
Milorad Kojic
William K Holloman
Cornell University · US

Funding

REC1 GENE CONTROLLING RECOMBINATION IN USTILAGOR01GM042482 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HOLLOMAN, WILLIAM K. · 1989 to 2013
$4.3M
Mechanisms of Brh2-Promoted Recombinatinal RepairR01GM079859 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HOLLOMAN, WILLIAM K. · 2007 to 2015
$2.8M
NIGMS NIH HHS GM42482NIGMS NIH HHS GM79859NIGMS NIH HHS R01 GM042482NIGMS NIH HHS R01 GM079859
6 · The paper itself

Abstract

Dss1 is an intrinsically unstructured polypeptide that partners with the much larger Brh2 protein, the BRCA2 ortholog in Ustilago maydis, to form a tight complex. Mutants lacking Dss1 have essentially the same phenotype as mutants defective in Brh2, implying that through physical interaction Dss1 serves as a positive activator of Brh2. Dss1 associates with Brh2 through an interaction surface in the carboxy-terminal region. Certain derivatives of Brh2 lacking this interaction surface remain highly competent in DNA repair as long as a DNA-binding domain is present. However, the Dss1-independent activity raises the question of what function might be met in the native protein by having Brh2 under Dss1 control. Using a set of Brh2 fusions and truncated derivatives, we show here that Dss1 is capable of exerting control when there is a cognate Dss1-interacting surface present. We find that association of Dss1 attenuates the DNA binding potential of Brh2 and that the amino-terminal domain of Brh2 helps evict Dss1 from its carboxy-terminal interaction surface. The findings presented here add to the notion that Dss1 serves in a regulatory capacity to dictate order in association of Brh2's amino-terminal and carboxy-terminal domains with DNA.

Indexed as

DNA-Binding ProteinsDNA RepairFungal ProteinsProtein BindingUstilagoDNA-Binding ProteinsFungal Proteins

Identifiers

PMID23094644
PMCPMC3617921
OpenAlexW2038812178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.